Its expression, low in healthy kidneys, has been identified in all components of the nephron and in the collecting duct; the activation of CB1R contributes to multiple renal diseases through the mitogen-activated protein kinase (MAPK) pathway [64,65,66]. Here, CNR1 is linked to kidney disorder.